Eli Lilly's stock has seen a 15% increase over the last year. However, it has experienced some volatility, with a decline over the last month and a 20% drop over the past six months. Despite these short-term fluctuations, Eli Lilly has outperformed the S&P 500, with a 96% increase over the longer term.